Movement Disorders in Psychiatry

Antonio L. Teixeira, MD, PhD, MSc, is Professor of Psychiatry and Neurology at University of Texas Health Houston where he leads the Neuropsychiatry Program. Dr. Teixeira is involved in research and clinical care of behavioral disorders in patients with Huntington's disease, Parkinson's disease, and other neurodegenerative diseases. Erin Furr Stimming, MD, is Professor of Neurology and founding Director of the Huntington's Disease Society of America Center of Excellence at University of Texas Health Houston. Dr. Furr Stimming is Fellow of the American Academy of Neurology and Director of the Neurology clerkship at McGovern Medical School. She devotes her time to clinical care and research for individuals with Huntington's disease, Parkinson's disease, and other movement disorders in addition to educating future physicians. William G. Ondo, MD, is Director of the Movement Disorder Clinic at Houston Methodist Hospital and Professor of Neurology at WeillCornell Medical School and Texas A&M. Dr. Ondo has served as primary, treating, and sub-investigator for many research projects involving adult and pediatric movement disorder research.

• Table of Contents Preface Part I: Movement Disorders Overview Chapter 1: Introduction to the Movement Disorders: Definition and Clinical PhenotypesErin Furr-Stimming, Jorge Patino Murillas, and William G. Ondo Chapter 2: Pathophysiology of Primary and Secondary Movement DisordersClaudio Da Cunha, William Sánchez-Luna, Fernando Henrique Teixeira Zonzini, Daniel R. Benke, and José Augusto Pochapski Part II: Movement Disorders Associated with Psychotropics Chapter 3: Dopamine Antagonist-Induced ParkinsonismAbdulmunaim M. Eid and William G. Ondo Chapter 4: AkathisiaSatyajit Mohite, Ossama T. Osman, Lokesh Shahani, and Antonio L. Teixeira Chapter 5: Tardive DyskinesiaVinicius Sousa Pietra Pedroso, João Vinícius Salgado, and Antonio L. Teixeira Chapter 6: Serotonin Syndrome and Neuroleptic Malignant SyndromeHaitham Salem, Brittany Finocchio, and Teresa Pigott Chapter 7: Movement Disorders Associated with SSRIsJennifer G. Goldman and Carlos Manuel Guerra Galicia Chapter 8: The Under Recognized Movement Disorders Associated with Mood Stabilizers: Lithium, Valproate, Carbamazepine, LamotrigineMelody Badii and William G. Ondo Chapter 9: Movement Disorders Associated with Stimulants and Other Drugs of AbuseLuiz Paulo Vasconcelos, Jordi Gandini, Antonio L. Teixeira, and Mario Manto Part III: Movement Disorders Seen in Primary Psychiatric Disorders Chapter 10: Neurological Soft Signs in Schizophrenia Spectrum DisordersJohannes Schröder and Christina J. Herold Chapter 11: Stereotypies in Childhood Developmental Disorders and Neurodegenerative DiseasesJoohi Jimenez-Shahed Chapter 12: Catatonia and Hypokinetic Movement DisordersNidaullah Mian, Carla Bejjani, and Raja Mehanna Chapter 13: Functional Movement DisordersJennifer S. Sharma and Alberto J. Espay Part IV: Diseases with Concurrent Psychiatric and Movement Disorders Symptoms Chapter 14: Tics and Tourette SyndromeAbhishek Lenka and Joseph Jankovic Chapter 15: Huntington's DiseaseNatalia Pessoa Rocha, Andy Liu, Karen Anderson, and Erin Furr-Stimming Chapter 16: Behavioral Abnormalities in Other Genetic and Non-Genetic Causes of ChoreaRicardo Maciel, Débora Palma Maia, and Francisco Cardoso Chapter 17: Parkinson's Disease and Atypical Parkinsonian SyndromesJulia Ridgeway-Diaz and Laura Marsh Chapter 18: Frontotemporal Dementia: Symptoms, Distinguishing Features, Genetics, Pathology, and Associated Movement DisordersAlbert Y. Amran, Avram S. Bukhbinder, and Paul E. Schulz Chapter 19: Restless Legs Syndrome and Psychiatric IssuesEmmanuel H. During and John W. Winkelman Chapter 20: Neurometabolic DiseasesNivedita Thakur, Moira Black, Sam Nicholas Russo, and Mary Kay Koenig Chapter 21: Autoimmune and Paraneoplastic EncephalopathiesJames F. Rini, Bradley T. Peet, and Michael D. Geschwind